Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/2 study of PRLX 93936 in multiple myeloma, focusing on safety, efficacy, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PRLX 93936

Snippet

Sponsor: Prolexys Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN